Laurel Wealth Advisors (North Carolina)’s Fate Therapeutics FATE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-170	Closed	-$10K	–	676
2021 Q4	$10K	Hold	170	–	–	﹤0.01%	407
2021 Q3	$10K	Hold	170	–	–	﹤0.01%	413
2021 Q2	$15K	Buy	+170	New	+$15K	﹤0.01%	411